Small molecule-based Lifespan extension therapy: PDGF-B inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 2/May/2015, 07.08 am

Small molecule-based Lifespan extension therapy: PDGF-B inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 2/May/2015, 07.08 am

Small molecule-based Lifespan extension therapy: PDGF-B inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 2/May/2015, 07.08 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Small molecule-based Lifespan extension therapy: PDGF-B inhibits senescence and  extends life span by down regulating the expression of  adenylate cyclase 5 (ADCY5), 2/May/2015, 07.07 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests, for the first time, that PDGF-B may extend the lifespan of an individual by suppressing ADCY5/AC5 expression. Thus, pharmacological formulations encompassing PDGF-B activators may be used to extend the life-span of an individual.

Undisclosed information: How PDGF-B suppresses the expression of  adenylate cyclase 5 (ADCY5)